Vega M A
Institut für Virologie and Immunbiologie der Universität, Würzburg, Federal Republic of Germany.
Hum Genet. 1991 Jul;87(3):245-53. doi: 10.1007/BF00200899.
The ideal approach to gene therapy of hereditary diseases or gene correction therapy is considered. The advantages, disadvantages and limits of gene targeting by homologous recombination are discussed with regard to its possible application in gene correction therapy and in comparison with retroviral-mediated gene complementation therapy.
本文探讨了遗传性疾病基因治疗或基因矫正治疗的理想方法。讨论了同源重组基因靶向在基因矫正治疗中的可能应用及其优缺点,并与逆转录病毒介导的基因互补治疗进行了比较。